Oncologists Weigh Options As CMS Reiterates No Drug Delivery Post-PHE

By Gabrielle Wanneh / May 19, 2023 at 2:59 PM
The Community Oncology Alliance (COA) is weighing its legal and legislative options after being informed by CMS hours before the COVID-19 public health emergency ended midnight last Thursday that the agency was sticking by its plan to prohibit physicians from delivering outpatient prescription drugs to patients’ homes via the mail or similar delivery options post PHE, COA Executive Director Ted Okon told Inside Drug Pricing . A lawsuit would be the most expedient form of action, as legislation to address...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.